百日咳杆菌粘着素的分子克隆、表达、纯化及生物学特性研究

大肠杆菌中克隆了编码百日咳杆菌粘着素（Ｐｅｒｔａｃｔｉｎ,Ｐｒｎ）１．９ｋｂ的结构基因,获得了４株表达Ｐｒｎ的重组菌株,以融合蛋白的形式,对Ｐｒｎ进行了表达。Ｐｒｎ融合蛋白的表达量占细胞总蛋白量的４６．４％。融合蛋白纯度达８９．２％。免疫印迹证明,抗天然Ｐｒｎ的单克隆抗体ＢＰＥ３能识别重组菌中及纯化的Ｐｒｎ融合蛋白。Ｐｒｎ融合蛋白能与抗百日咳杆菌Ⅰ相血清发生特异凝集反应。Ｐｒｎ融合蛋白及重组菌免疫小鼠后,对百日咳杆菌毒力株１８３２３的脑内攻击,保护率达６０～６２．５％。     

无细胞百日咳菌苗纯度和生物学特性研究

本文对无细胞百日咳菌苗的纯度、免疫力和毒性进行了研究。实验证明菌苗中不仅含有百日咳毒素（ＰＴ）和丝状血凝素（ＦＨＡ）,而且还含有百日咳凝集素和百日咳粘着素。菌苗的纯度为５０％－９５．７％,菌苗中ＰＴ和ＦＨＡ的比例为１：１－１：１８。     

Pertactin antigens extracted from Bordetella pertussis and Bordetella bronchiseptica differ in the isoelectric point

Pertactin, which is a membrane-associated antigen of Bordetella pertussis and which is present in many acellular vaccines against whooping cough, has been reported to be similar to the homologous protein in Bordetella bronchiseptica. By running parallel experiments using proteins derived from the two species, we show that the isoelectric point of pertactin from B. pertussis is lower than reported and clearly distinguishable from the homologous protein of B. bronchiseptica. Received: 9 April 1997 / Accepted: 20 May 1997     

The virulence factors of Bordetella pertussis: a matter of control

Bordetella pertussis is the causative agent of whooping cough, a contagious childhood respiratory disease. Increasing public concern over the safety of whole-cell vaccines led to decreased immunisation rates and a subsequent increase in the incidence of the disease. Research into the development of safer, more efficacious, less reactogenic vaccine preparations was concentrated on the production and purification of detoxified B. pertussis virulence factors. These virulence factors include adhesins such as filamentous haemagglutinin, fimbriae and pertactin, which allow B. pertussis to bind to ciliated epithelial cells in the upper respiratory tract. Once attachment is initiated, toxins produced by the bacterium enable colonisation to proceed by interfering with host clearance mechanisms. B. pertussis co-ordinately regulates the expression of virulence factors via the Bordetella virulence gene (bvg) locus, which encodes a response regulator responsible for signal-mediated activation and repression. This strict regulation mechanism allows the bacterium to express different gene subsets in different environmental niches within the host, according to the stage of disease progression.